Compugroup Medical (COP) Given a €60.00 Price Target by Commerzbank Analysts

Compugroup Medical (ETR:COP) has been given a €60.00 ($71.43) price objective by stock analysts at Commerzbank in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. Commerzbank’s price target would indicate a potential upside of 14.83% from the stock’s current price.

Several other equities analysts have also recently commented on COP. set a €61.00 ($72.62) price target on shares of Compugroup Medical and gave the company a “buy” rating in a research report on Wednesday, October 18th. Warburg Research set a €56.00 ($66.67) price target on shares of Compugroup Medical and gave the company a “buy” rating in a research report on Thursday, December 14th. Berenberg Bank set a €53.00 ($63.10) price target on shares of Compugroup Medical and gave the company a “neutral” rating in a research report on Monday, October 16th. Deutsche Bank set a €60.00 ($71.43) price target on shares of Compugroup Medical and gave the company a “buy” rating in a research report on Monday, October 16th. Finally, Baader Bank set a €52.00 ($61.90) price target on shares of Compugroup Medical and gave the company a “neutral” rating in a research report on Wednesday, November 15th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Compugroup Medical presently has a consensus rating of “Buy” and an average target price of €58.43 ($69.56).

Compugroup Medical (COP) traded up €0.95 ($1.13) during trading on Thursday, reaching €52.25 ($62.20). 163,220 shares of the company traded hands, compared to its average volume of 56,213. Compugroup Medical has a 12-month low of €36.12 ($43.00) and a 12-month high of €59.25 ($70.54). The firm has a market cap of $2,780.00 and a P/E ratio of 63.72.

ILLEGAL ACTIVITY WARNING: “Compugroup Medical (COP) Given a €60.00 Price Target by Commerzbank Analysts” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/27/compugroup-medical-cop-given-a-60-00-price-target-by-commerzbank-analysts.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply